Euclidean Capital
Overview
Based in New York and Seattle, we use machine learning to seek history's best lessons for evaluating individual companies as potential long-term investments. The lessons we found to be fruitful involve buying good companies when they are offered at very low prices. By embedding these lessons into a systematic investment process, we aspire to protect our investors against unproductive behavioral biases.\\Our founders Michael Seckler and John Alberg pursued this mission because they had their own money to invest after building a company over a decade and selling it to a Fortune 500 company. The two entrepreneurs wanted an alternative to the short-term focus, risks of leverage, misaligned incentives, and reliance on qualitative analysis that in various combinations accompany many of today's asset management options.\\Learn more about Euclidean's founders and unique investment strategy by visiting our website, and reading our letters to investors.
Investment Focus
- Strong management teams
- Innovative business models
- Scalable growth potential
- Competitive market positioning
- Clear exit strategies
Portfolio Companies
Reach Euclidean Capital directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Euclidean Capital
What sectors does Euclidean Capital invest in?
Euclidean Capital invests in Financial Services, Technology, Healthcare, Energy, Consumer Goods and Real Estate, and is based in New York, New York, United States. Euclidean Capital is listed as a family office in the ConnectSafely investor database.
What stage does Euclidean Capital invest at?
Euclidean Capital backs companies at Early Stage, Growth, Late Stage, Pre-IPO and Buyout, writing cheques of 1M - 50M.
Which regions does Euclidean Capital invest in?
Euclidean Capital invests across United States, Canada, Japan, Australia, Europe and Asia.
What companies has Euclidean Capital invested in?
Euclidean Capital's portfolio includes 23andMe, Surrozen, Alector, Savvy Wealth, April, Neurona Therapeutics, Judo Bio and Leal Therapeutics.
How do I contact Euclidean Capital?
Euclidean Capital's contact details — including phone and LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of the team.
Last updated · Source: ConnectSafely investor database
